Neoglycosides
08/05/2010
ACHN-490 Overview: Web Conference
Hosted in August 2010 by J. Kevin Judice, CEO & CSO
- Listen to a recording of the web conference (use password: 90215265, pop-up windows must be enabled in your browser)
- Download a PDF of the presentation
07/30/2010
New aminoglycoside antibiotics
Paola Dozzo & Heinz E Moser
Expert Opin. Ther. Patents (2010) 20(10)
Access this publication at informahealthcare.com
Paola Dozzo & Heinz E Moser
Expert Opin. Ther. Patents (2010) 20(10)
Access this publication at informahealthcare.com
04/10/2010
Ototoxic Potential of ACHN-490 Compared to Gentamicin and Amikacin in the Guinea Pig
CF Kostrub, DF Dolan, RA Altschuler, RL Tapp, TJ Baird, JA Boggs, JB Bruss
Achaogen Inc, MPI Research, Kresge Hearing Research Institute
ECCMID 2010, poster # P-1249
CF Kostrub, DF Dolan, RA Altschuler, RL Tapp, TJ Baird, JA Boggs, JB Bruss
Achaogen Inc, MPI Research, Kresge Hearing Research Institute
ECCMID 2010, poster # P-1249
02/09/2010
Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
Gengrong Lin, Lois M. Ednie, and Peter C. Appelbaum
Antimicrobial Agents and Chemotherapy, doi:10.1128/AAC.01350-09
Access this publication at aac.asm.org
Gengrong Lin, Lois M. Ednie, and Peter C. Appelbaum
Antimicrobial Agents and Chemotherapy, doi:10.1128/AAC.01350-09
Access this publication at aac.asm.org
10/01/2009
ACHN-490, a Neoglycoside with Potent In Vitro Activity against Multidrug-Resistant Klebsiella pneumoniae Isolates
Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer, Eliana S. Armstrong, Yuvraj Choudhary, James B. Aggen, and Robert A. Bonomo
Antimicrobial Agents and Chemotherapy, October 2009, p. 4504-4507, Vol. 53, No. 10
Access this publication at aac.asm.org
Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer, Eliana S. Armstrong, Yuvraj Choudhary, James B. Aggen, and Robert A. Bonomo
Antimicrobial Agents and Chemotherapy, October 2009, p. 4504-4507, Vol. 53, No. 10
Access this publication at aac.asm.org
09/13/2009
Activity of the Neoglycoside ACHN-490 Against a Contemporary Collection of Clinical Isolates Including Antimicrobial-Resistant Strains
RN Jones, ES Armstrong, JB Aggen, DJ Biedenbach, GH Miller
JMI Laboratories, Achaogen Inc.
ICAAC 2009, poster # F1-846a
RN Jones, ES Armstrong, JB Aggen, DJ Biedenbach, GH Miller
JMI Laboratories, Achaogen Inc.
ICAAC 2009, poster # F1-846a
09/13/2009
Pharmacokinetics of the Novel Neoglycoside ACHN-490 in Mouse, Rat, and Dog
Robert T. Cass, Jenny V. McKinnell, Bo Xie, Dane E. Karr, Donald E. Schmidt Jr.
Achaogen, Inc.
ICAAC 2009, poster # F1-846
Robert T. Cass, Jenny V. McKinnell, Bo Xie, Dane E. Karr, Donald E. Schmidt Jr.
Achaogen, Inc.
ICAAC 2009, poster # F1-846
09/13/2009
In Vivo Efficacy of the Neoglycoside ACHN-490 Against Enterobacteriaceae and MRSA Pharmacokinetics of the Novel Neoglycoside ACHN-490 in Mouse, Rat, and Dog
Noe Reyes, James B. Aggen, Corwin F. Kostrub
Achaogen, Inc.
ICAAC 2009, poster # F1-845
Noe Reyes, James B. Aggen, Corwin F. Kostrub
Achaogen, Inc.
ICAAC 2009, poster # F1-845
09/13/2009
Activity of ACHN-490 in Combination with Daptomycin, Ceftobiprole, or Linezolid Against 25 methicillin-resistant Staphylococcus aureus by Synergy Time-kill
Gengrong Lin, Lois M. Ednie, Peter C. Appelbaum
Department of Pathology, Hershey Medical Center
ICAAC 2009, poster # F1-844
Gengrong Lin, Lois M. Ednie, Peter C. Appelbaum
Department of Pathology, Hershey Medical Center
ICAAC 2009, poster # F1-844
09/13/2009
Activity of ACHN-490 Against Complicated Urinary Tract Infection (cUTI) Pathogens From the United States (USA) and Europe (EU)
DJ Biedenbach, RN Jones, ES Armstrong, JB Aggen, GH Miller
JMI Laboratories, Achaogen Inc.
ICAAC 2009, poster # F1-843
DJ Biedenbach, RN Jones, ES Armstrong, JB Aggen, GH Miller
JMI Laboratories, Achaogen Inc.
ICAAC 2009, poster # F1-843
09/13/2009
Activity of ACHN-490, a Novel Neoglycoside Antibiotic, Against Contemporary Gram-negative Clinical Isolates from Brooklyn, NY Hospitals
Claudiu Georgescu, Don-Antonio Martin, Simona Bratu, John Quale, David Landman
SUNY Downstate Medical Center
ICAAC 2009, poster # F1-842
Claudiu Georgescu, Don-Antonio Martin, Simona Bratu, John Quale, David Landman
SUNY Downstate Medical Center
ICAAC 2009, poster # F1-842
09/13/2009
The Bactericidal Activity of the Neoglycoside ACHN-490 Against Aminoglycoside-Resistant Bacteria
Gary Zurenko, Douglas Stapert, Mary Knechtel, Nanette Nichols, Dean Shinabarger, Eliana S. Armstrong, James B. Aggen, Lee Ann Feeney, Aya Kubo, Rowena D. Matias, George H. Miller
Micromyx, Achaogen Inc.
ICAAC 2009, poster # F1-841
Gary Zurenko, Douglas Stapert, Mary Knechtel, Nanette Nichols, Dean Shinabarger, Eliana S. Armstrong, James B. Aggen, Lee Ann Feeney, Aya Kubo, Rowena D. Matias, George H. Miller
Micromyx, Achaogen Inc.
ICAAC 2009, poster # F1-841
09/13/2009
Synthesis, Structure, and in vitro Activity of the Neoglycoside ACHN-490
James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum, Paola Dozzo, Martin S. Linsell, Micah J. Gliedt, Darin J. Hildebrandt, Lee Ann Feeney,Aya Kubo, Rowena D. Matias, Sara Lopez, Marcela Gomez, Kenneth B. Wlasichuk, Raymond Diokno, George H. Miller, Heinz E. Moser
Achaogen, Inc.
ICAAC 2009, poster # F1-840
James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum, Paola Dozzo, Martin S. Linsell, Micah J. Gliedt, Darin J. Hildebrandt, Lee Ann Feeney,Aya Kubo, Rowena D. Matias, Sara Lopez, Marcela Gomez, Kenneth B. Wlasichuk, Raymond Diokno, George H. Miller, Heinz E. Moser
Achaogen, Inc.
ICAAC 2009, poster # F1-840
07/21/2009
Quantitative comparison of aminoglycoside nephrotoxicity in rats for effective screening and evaluation of new derivatives, and dosing rationales that minimise toxicity
C.F. Kostrub, R. Diokno, J. Aggen, G. Miller, K. Judice, P. Tulkens
Achaogen Inc., Université catholique de Louvain
ECCMID 2009 poster P 1979
C.F. Kostrub, R. Diokno, J. Aggen, G. Miller, K. Judice, P. Tulkens
Achaogen Inc., Université catholique de Louvain
ECCMID 2009 poster P 1979
07/21/2009
Surveying aminoglycoside-resistance mechanisms: a tool for the development of neoglycosides
E. Armstrong, D. Biedenbach, R. Jones, G. Miller
Achaogen Inc., JMI Laboratories
ECCMID 2009 poster P 643
E. Armstrong, D. Biedenbach, R. Jones, G. Miller
Achaogen Inc., JMI Laboratories
ECCMID 2009 poster P 643
07/21/2009
Ten-year trend in aminoglycoside resistance from a worldwide collection of Gram-negative pathogens (1998-2007)
D. Biedenbach, R. Jones, G. Miller, E. Armstrong
JMI Laboratories, Achaogen, Inc.
ECCMID 2009 poster P 636
D. Biedenbach, R. Jones, G. Miller, E. Armstrong
JMI Laboratories, Achaogen, Inc.
ECCMID 2009 poster P 636
